Users online: 2471    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 3
First page : ( 1523) Last page : ( 1526)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00277.2

Regulatory Requirement and Registration Process of Generic Drugs in Japan

Poovarasan D*, Manikandan K., Kamaraj R.

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Kanchipuram, Tamil Nadu, India

*Corresponding Author E-mail: poovarasan11355@gmail.com

Online published on 22 April, 2020.


Generic product is established by Pharmaceuticals and Medical Devices Agency to be approved for marketing in Japan respectively. Japan market is important to pharmaceutical industry. Japan is under one of the Regulated markets and owning the world's second largest pharmaceutical market. Generic drugs are replaceable with original proprietary drugs, as they have the same active pharmaceutical ingredients, strength, quality, effects, dosage forms, indications, directions and dosage. The cost of generic product is lower than innovator product, because the developmental cost is low. The expansion of medical expenses is an important issue in many countries, including Japan, Europe and the USA and promotion of generic drugs has been demanded to solve this issue in Japan. An overview of checklist for requirements and registration process of generic product in Japan is provided.



Generic product, PMDA, Regulatory market, Regulatory requirements, Registration.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
490,349,143 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.